These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21199224)

  • 21. Comparative evaluation of two different dosage calculation protocols of iodine-131 in the treatment of hyperthyroidism.
    Thientunyakit T; Thongmak S; Premprapha T
    J Med Assoc Thai; 2010 Aug; 93(8):969-77. PubMed ID: 20718174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized study of the efficacy and cost-effectiveness of high and low dose regimens of I-131 treatment in hyperthyroidism.
    Pusuwan P; Tuntawiroon M; Sritongkul N; Chaudakshetrin P; Nopmaneejumruslers C; Komoltri C; Thepamongkhol K; Khiewvan B; Tuchinda P; Sriussadaporn S
    J Med Assoc Thai; 2011 Mar; 94(3):361-8. PubMed ID: 21560845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use and efficacy of radioiodine therapy in the treatment of hyperthyroidism].
    Mihailović J; Malesević M; Stefanović L; Krkljus D
    Med Pregl; 1995; 48(11-12):412-5. PubMed ID: 8643057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease.
    Nordyke RA; Gilbert FI
    J Nucl Med; 1991 Mar; 32(3):411-6. PubMed ID: 2005449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usage of a fixed dose of radioactive iodine for the treatment of hyperthyroidism: one-year outcome in a regional hospital in Hong Kong.
    Yau JS; Chu KS; Li JK; Chan KW; Lau IT; Yum SW; Chan CW; Mo LK; Kwan WK
    Hong Kong Med J; 2009 Aug; 15(4):267-73. PubMed ID: 19652233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma.
    Kim EY; Kim TY; Kim WG; Yim JH; Han JM; Ryu JS; Hong SJ; Yoon JH; Gong G; Kim WB; Shong YK
    Nucl Med Commun; 2011 Oct; 32(10):954-9. PubMed ID: 21849927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of the administered radioiodine doses for the treatment of hyperthyroidism in Belgium.
    Tondeur M; Glinoer D; Sand A; Verelst J; Ham H
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):206-9. PubMed ID: 16886961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of standard ten millicurie dose of radio-iodine in management of autonomously functioning toxic thyroid nodules.
    Sharma R; Bhatnagar A; Mondal A; Kashyap R; Khanna CM
    J Assoc Physicians India; 1995 Mar; 43(3):167-9, 172. PubMed ID: 11256900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of fractionated radioiodine therapy in 696 patients with hyperthyroidism and 690 patients with non-toxic goiter].
    Klein B; Klein E; Horster FA
    Nuklearmedizin; 1989 Aug; 28(4):129-36. PubMed ID: 2780331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of recurrence and hypothyroidism after radioiodine treatment in patients with hyperthyroidism in Trakya, a mild iodine deficiency area, during the period 1991-2003.
    Ustun F; Yuksel M; Durmus-Altun G; Kaya M; Cermik TF; Sarikaya A; Berkarda S
    Ann Nucl Med; 2005 Dec; 19(8):737-42. PubMed ID: 16445003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hyperthyroidism with standard doses of radioiodine aiming at ablation.
    Eriksson E; Eriksson K; Wahlberg P
    Acta Med Scand; 1985; 217(1):55-60. PubMed ID: 3976432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fixed 30 mCi (1110 MBq)
    Pereira LSB; Riguetto CM; Neto AM; Tambascia MA; Ramos CD; Zantut-Wittmann DE
    World J Nucl Med; 2021; 20(4):349-354. PubMed ID: 35018149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 131I therapy for 345 patients with refractory severe hyperthyroidism: Without antithyroid drug pretreatment.
    Ding Y; Xing J; Fang Y; Wang Y; Zhang Y; Long Y
    Exp Biol Med (Maywood); 2016 Feb; 241(3):290-5. PubMed ID: 26341470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radioiodine therapy of thyrotoxicosis in a central hospital].
    Sonne HS; Larsen B; Asfeldt VH
    Ugeskr Laeger; 1993 Oct; 155(43):3483-6. PubMed ID: 8256341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.